These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22020456)

  • 1. Buprenorphine as a safe alternative to methadone in a patient with acquired long QT syndrome: a case report.
    de Jong IM; de Ruiter GS
    Neth Heart J; 2013 May; 21(5):249-52. PubMed ID: 22020456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen.
    Fanoe S; Hvidt C; Ege P; Jensen GB
    Heart; 2007 Sep; 93(9):1051-5. PubMed ID: 17344330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block.
    Tran PN; Sheng J; Randolph AL; Baron CA; Thiebaud N; Ren M; Wu M; Johannesen L; Volpe DA; Patel D; Blinova K; Strauss DG; Wu WW
    PLoS One; 2020; 15(11):e0241362. PubMed ID: 33157550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations.
    Stallvik M; Nordstrand B; Kristensen Ø; Bathen J; Skogvoll E; Spigset O
    Drug Alcohol Depend; 2013 Apr; 129(1-2):88-93. PubMed ID: 23084592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful transition to buprenorphine in a patient with methadone-induced torsades de pointes.
    Esses JL; Rosman J; Do LT; Schweitzer P; Hanon S
    J Interv Card Electrophysiol; 2008 Nov; 23(2):117-9. PubMed ID: 18686025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Torsades de pointes associated with methadone and voriconazole.
    Reinhold JA; Sanoski CA; Russo AM; Cooper JM; Spinler SA
    BMJ Case Rep; 2009; 2009():. PubMed ID: 22190985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone induced torsades de pointes and ventricular fibrillation: A case review.
    Khalesi S; Shemirani H; Dehghani-Tafti F
    ARYA Atheroscler; 2014 Nov; 10(6):339-42. PubMed ID: 25815024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
    Trinkley KE; Page RL; Lien H; Yamanouye K; Tisdale JE
    Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
    Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence or Absence of QTc Prolongation in Buprenorphine-Naloxone Among Youth With Opioid Dependence.
    Poole SA; Pecoraro A; Subramaniam G; Woody G; Vetter VL
    J Addict Med; 2016; 10(1):26-33. PubMed ID: 26690291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone-associated Q-T interval prolongation and torsades de pointes.
    Stringer J; Welsh C; Tommasello A
    Am J Health Syst Pharm; 2009 May; 66(9):825-33. PubMed ID: 19386945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of buprenorphine on cardiac repolarization in a patient with methadone-related torsade de pointes.
    Krantz MJ; Garcia JA; Mehler PS
    Pharmacotherapy; 2005 Apr; 25(4):611-4. PubMed ID: 15977920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citalopram and the KCNE1 D85N variant: a case report on the implications of a genetic modifier.
    Marstrand P; Christensen AH; Bartels ED; Theilade J
    Eur Heart J Case Rep; 2018 Dec; 2(4):yty106. PubMed ID: 31020182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise?
    Romero J; Baldinger SH; Goodman-Meza D; Engstrom K; Valencia CR; Golive A; Medrano F; Rangasamy S; Makkiya M; Fisher JD; Gross J; Krumerman A; Kim S; Garcia MJ; Di Biase L; Ferrick KJ
    J Interv Card Electrophysiol; 2016 Jan; 45(1):37-45. PubMed ID: 26589717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long QT Syndrome Unveiled by a Fatal Combination of Medications and Electrolyte Abnormalities.
    Sethi P; Treece J; Pai V; Onweni C
    Cureus; 2017 Aug; 9(8):e1581. PubMed ID: 29057193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone and Corrected QT Prolongation in Pain and Palliative Care Patients: A Case-Control Study.
    Juba KM; Khadem TM; Hutchinson DJ; Brown JE
    J Palliat Med; 2017 Jul; 20(7):722-728. PubMed ID: 28186837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.
    Wedam EF; Bigelow GE; Johnson RE; Nuzzo PA; Haigney MC
    Arch Intern Med; 2007 Dec; 167(22):2469-75. PubMed ID: 18071169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
    Othong R; Devlin JJ; Kazzi ZN
    Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: A 56-year-old woman presenting with torsades de pointes and cardiac arrest associated with levosimendan administration and underlying congenital long QT syndrome type 1.
    Zha F; Li X; Yin H; Huang D; Du Y; Zhou C
    Heliyon; 2024 Apr; 10(8):e29300. PubMed ID: 38644859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrected QT Interval Prolongation in Pediatric and Young Adult Patients on Methadone for Cancer-Related Pain.
    Madden K; Jo E; Williams JL; Liu D; Bruera E
    J Pain Symptom Manage; 2019 Oct; 58(4):678-684. PubMed ID: 31195079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.